Strides Pharma Science reported a consolidated net profit of Rs 93.23 crore in Q1 FY25 as against a net loss of Rs 131.34 crore posted in Q2 FY24.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Strides Pharma Science reported a consolidated net profit of Rs 93.23 crore in Q1 FY25 as against a net loss of Rs 131.34 crore posted in Q2 FY24.
| Subscribe To Our Free Newsletter |
